CAS: 98813-11-7

Oxohygrolidin is an anticancer analog that has shown promising results in inhibiting the growth of cancer cells and tumors. It acts as a potent inhibitor of thymidine kinase, which is a key enzyme involved in DNA synthesis. Oxohygrolidin induces apoptosis in human cancer cells by disrupting the normal functioning of kinases, which are essential for cell survival and proliferation. This compound has been shown to be effective against a range of cancers, including breast, lung, and prostate cancer. Oxohygrolidin is also being studied as a potential therapy for Chinese hamster ovary (CHO) cells, which are commonly used in biotechnology research. This compound has been identified as one of the most potent inhibitors of protein kinases found in urine samples from cancer patients.